TAYLOR ZURO: Open Payments
NPI 1265908735 · TARENTUM, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$824 in 39 payments from 10 companies in 2025. Trend: 2023 $1,207 · 2024 $998 · 2025 $824
Food & beverage: $824
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 5 | $244 |
| ABBVIE INC. | 17 | $199 |
| Regeneron Healthcare Solutions, Inc. | 4 | $116 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $84 |
| GENZYME CORPORATION | 3 | $74 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $41 |
| Ardelyx, Inc. | 1 | $18 |
| Janssen Biotech, Inc. | 1 | $17 |
| Novo Nordisk Inc | 1 | $17 |
| Phathom Pharmaceuticals, Inc. | 2 | $14 |
Products named: REZDIFFRA, DUPIXENT, LINZESS, ENTYVIO, XIFAXAN, SKYRIZI, MAVYRET, IBSRELA.
Industry payments across PA — which companies pay providers there.
